Get caught up! Check out @abc13houston's recent news report on Pulmotect, Inc. here: abc13.com/coronavirus-pr…
#MotivationMonday #Health #clinicalresearch #COVID19
English
Pulmotect Inc.
69 posts
Pulmotect Inc.
@pulmotect
Developing PUL-042, an inhaled therapeutic designed to prevent and treat respiratory infections
Houston, TX Katılım Mart 2017
60 Takip Edilen185 Takipçiler
"Scott and his team are hopeful the drug could be used to help frontline workers protect their lungs against the #coronavirus as they treat infected patients. The drug has already passed phase one trials."
#healthcare #COVID19 #HealthcareHeroes #FridayThoughts #Trending
ABC13 Houston@abc13houston
Houston company testing drug to protect against COVID-19 abc13.co/2LdnG24
English
#FDA approval in hand, we start two Phase-2 clinical trials against #COVID19 this week.
Details here: pulmotect.com/wp-content/upl…
#covid19 #health #trending #science #coronavirus @US_FDA #TuesdayThoughts #news #healthcare
English
@YAYshamsaldeen Thank you - to be clear, it may have potential treatment as well as prophylactic therapeutic effects against Covid-19 in humans. We don't know yet, but we are also hopeful. Stay safe!
English
تابع التغريدة أعلاه...
شركة بلموتيكت تتفاعل مع سؤال طرحه أحد الأعزاء بتوضيحها أن فاعلية المركب الدوائي الذي يجربونه
PUL-042
له تأثير علاجي بالإضافة إلى مفعوله الوقائي
🌹🌹🌹
شكرا
@pulmotect
نتمنى أن يكلل مشروعكم بالنجاح، و الاعتماد النهائي قريبا
(51)
twitter.com/pulmotect/stat…
Pulmotect Inc.@pulmotect
@YAYshamsaldeen @miiiishal1 It may offer clinical benefit in reducing severity post-infection. Antiviral effects after an infection has been established in an animal model are shown here: ncbi.nlm.nih.gov/pmc/articles/P…
العربية
اعتماد دواء فافيلافير (فافيبيرافير) للاستخدام العلاجي التجريبي لمرضى كورونا
الجدير بالذكر ان هذا الدواء معتمد لعلاج الانفلونزا... لذلك هو آمن للبشر و يبقى اثبات جودته للكورونا
Favilavir approved as experimental coronavirus drug clinicaltrialsarena.com/news/china-fav… via @Clinical Trials Arena
العربية
@YAYshamsaldeen @miiiishal1 It may offer clinical benefit in reducing severity post-infection. Antiviral effects after an infection has been established in an animal model are shown here: ncbi.nlm.nih.gov/pmc/articles/P…
English
We would like to express our gratitude to all of our doctors, healthcare workers, scientists, and all other essential workers who are working so hard right now to get us through this #coronavirus pandemic.
#COVID19 #CoronaVirusUpdates #StayHomeSaveLives #NationalDoctorDay
English
@pumotect's PUL-042 has successfully prevented & treated a broad range of respiratory infections in animal models, including those of #coronavirus family members #SARS & #MERS. Learn more about PUL-042 below or visit: pulmotect.com
#COVID19 #CoronaUpdate #health #utmb
English
@pulmotect is making plans for a phase II clinical trial to test the ability of their immunemodulator PUL-042 in preventing and treating #COVID19. In preclinical studies, PUL-042 has been shown to be effective against other coronaviruses.
#coronavirus #StayHomeSaveLives #houston
Houston Chronicle@HoustonChron
Houston researchers test lung inhalant that could protect healthcare workers from COVID-19 bit.ly/2WEOz62
English
Check out @pulmotect's president, Brenton Scott, as he talks about PUL-042 and the pivot from treating pneumonia in cancer patients to treating pneumonia caused by #COVID19 on @FOX26Houston with @JoseGrinanFOX26
fox26houston.com/video/665300
#coronavirus #science #flattenthecurve
English
Update March 23 2020 - Pulmotect's Chairman, Leo Linbeck III, provides an update on plans for a Phase II clinical trial to mitigate impact of #COVID19. Stay tune for updates
#coronavirus #research #Houston #WednesdayThoughts #FlattenTheCurve #Science #healthcare #innovation
Fannin Innovation Studio@FanninStudio
@pulmotect Chairman & @FanninStudio founder Leo Linbeck III provides an update on Pulmotect’s plans for a Phase II clinical trial to mitigate impact of #COVID19. Learn more: pulmotect.com. #coronavirus #FlattenTheCurve #texas youtu.be/Tcd52BwIAaw
English
Pulmotect, Inc. – Bio-pharmaceutical company developing products for severe respiratory diseases ow.ly/KKAB30dZdX7
English
Mimicking the human lung will provide researchers a unique way to investigate new areas of research for #COPD
ow.ly/l7y750d5j4d
English
A Flu Pandemic Is Coming, But When, and How Bad Will It Be? #flu govtech.com/em/disaster/A-…
English
9 takeaways on clinical trials from the patient's view | Clinical Innovation + Technology ow.ly/Hc6p30dZd9v
English
Meet our experienced management team pulmotect.com/about/manageme…
English
Our scientific advisory board members include U.S. and european respiratory experts pulmotect.com/about/scientif…
English
COPD: Changes in the lungs, changes in the microbiome -- ScienceDaily ow.ly/9Pqh30dHagr
English
How COPD Affects Americans From Coast to Coast #COPD ow.ly/RBsC30dH9K1
English
Non-Invasive Ventilation Reduces Death from #COPD Breathing Failure | Medpage Today ow.ly/BW5z30dHud8
English